hrp0095p2-189 | Growth and Syndromes | ESPE2022

Does she need growth hormone treatment?

Elkina Stanimira , Halvadzhiyan Irina , Petrova Chayka

Growth retardation in children with type 1 diabetes (T1D) is mostly associated with longterm poor metabolic control or combination with other autoimmune diseases. Although rare it could be due to growth hormone deficiency. We present eleven-year-old girl, diagnosed with T1D at age of 2y6mo., on multiple daily injections (MDI) with analogues. She is raised in poor social conditions – low parental education and income, rare follow-up due to difficult access to healthcare p...

hrp0092p1-78 | GH and IGFs | ESPE2019

Premature Infants Born Small by Gestational Age: the Role of Insulin-like Growth Factor-1 in the Regulation of Postnatal Growth

Kovalenko Tatyana , Yuditskiy Anton , Petrova Irina

The role of insulin-like growth factor-1 (IGF-1) in the regulation of growth of children with intrauterine growth is currently being discussed, but the final point of view has not been achieved.Aim: to study the effect of IGF-1 in the dynamics of postnatal growth of premature infants with SGA in the first 5 years of life.Material and Methods: The prospective study included prematurity with SGA (gro...

hrp0092p2-185 | Growth and Syndromes (to include Turner Syndrome) | ESPE2019

Premature Infants Born Small to Gestational Age: Growth Dynamics in the First 5 Years of Life

Yuditskiy Anton , Kovalenko Tatyana , Petrova Irina

Prematurity combined with intrauterine growth retardation (small to gestational age, SGA) is a potential risk factor for adverse growth prognosis. There is insufficient evidence on this issue.Aim: to study the growth rates in preterm infants born small to gestational age, different gestational age in the first 5 years of life.Material and Methods: The prospective study included preterm infants with...

hrp0089p1-p151 | GH & IGFs P1 | ESPE2018

Growth of Premature Infants Born Small by Gestational Age

Kovalenko Tatyana , Yuditskiy Anton , Petrova Irina

Premature infants born small by gestational age (SGA) represent a potential cohort for growth retardation. However, up to the present time, questions of the frequency and severity of the growth deficit, the timing of the growth rate, the age of achievement of the population standard depending on the gestational age have been discussed.Aim: To assess the dynamics of growth of preterm infants born small by gestational age within 5 years of life, taking int...

hrp0084p3-1045 | Growth | ESPE2015

Small for Gestational Age Incidence in One of the Regions of the Russian Federation

Petrova Irina , Shtina Marina , Kovalenko Tatiana

Background: Intrauterine growth retardation (small for gestational age (SGA)) is connected with perinatal morbidity, neurological pathology and stature.Objective and hypotheses: The aim of our study is to estimate the incidence of SGA and its consequences in newborns and infants at the age 1.Method: The incidence of SGA among newborns in the Udmurt Republic (the region of the European part of the Russian Federation) has been studie...

hrp0094p2-217 | Fat, metabolism and obesity | ESPE2021

Nutritional status in premature infants born small by gestational age in the first 5 years of life

Kovalenko Tatyana , Yuditskiy Anton , Petrova Irina ,

There is not enough reasoned data on the dynamics of body weight indices in premature infants born small by gestational age (SGA).Aim: To study the nutritional status in premature babies born small by gestational age, in the first 5 years of life.Materials and Methods: The prospective study included preterm infant with SGA (n = 100) and prematurity corresponding to gestational age - AGA (n = 69) w...

hrp0094p2-249 | Growth hormone and IGFs | ESPE2021

Predictors of short stature in premature infants born small for gestational age

Yuditskiy Anton , Kovalenko Tatyana , Petrova Irina ,

Aim: to evaluate the frequency and predictors of short stature in preterm infants born small for gestational age (SGA), by the age of 5 years. Materials and Methods. We examined 100 premature babies (gestational age of 22-31 weeks – 18, 32-36 weeks – 82), born SGA with the tables Fenton T. R. et al. (2013). Protocol included an assessment of anthropometric indicators and IGF-1 levels in the blood at birth, at the ages of 1 and 5 years. The odds ratio...

hrp0097p2-213 | Adrenals and HPA Axis | ESPE2023

Pseudohypoaldosteronism in congenital anomaly of the kidneys and urinary tract – case presentation

Elkina Stanimira , Bozhanova Venetsiya , Halvadzhiyan Irina , Petrova Chayka

Introduction: Pseudohypoaldosteronism (PHA) is a clinical syndrome characterized by multiorgan or isolated renal tubular resistance to the effects of aldosterone, resulting in hyperkalemia, metabolic acidosis, and normal to high serum aldosterone levels. PHA may be primary (hereditary) or secondary (acquired). Primary forms are subclassified into two: PHA type 1 (salt-wasting) and PHA type 2 (salt-retaining). Secondary forms are typically associated with sever...